Trial Outcomes & Findings for Assessing the Time Demands of Cancer (NCT NCT05708703)

NCT ID: NCT05708703

Last Updated: 2025-09-16

Results Overview

Summary of mobile app smartphone collected data from daily surveys about time spent at home on cancer-related care tasks over 28 days, including taking medications, scheduling appointments, handling medical bills, managing symptoms, monitoring health status and arranging help/transportation.

• Recruitment status: ACTIVE_NOT_RECRUITING
• Target enrollment: 78 participants
• Primary outcome timeframe: 28 days
• Results posted on: 2025-09-16

Participant Flow

Participant milestones

Measure	Study Cohort Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Overall Study STARTED	78
Overall Study COMPLETED	60
Overall Study NOT COMPLETED	18

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Assessing the Time Demands of Cancer

Baseline characteristics by cohort

Measure	Study Cohort n=78 Participants Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	55 Participants n=5 Participants
Age, Categorical >=65 years	23 Participants n=5 Participants
Sex: Female, Male Female	78 Participants n=5 Participants
Sex: Female, Male Male	0 Participants n=5 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	4 Participants n=5 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	71 Participants n=5 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	3 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=5 Participants
Race (NIH/OMB) Asian	0 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	15 Participants n=5 Participants
Race (NIH/OMB) White	59 Participants n=5 Participants
Race (NIH/OMB) More than one race	2 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	2 Participants n=5 Participants
Region of Enrollment United States	78 participants n=5 Participants

PRIMARY outcome

Timeframe: 28 days

Summary of mobile app smartphone collected data from daily surveys about time spent at home on cancer-related care tasks over 28 days, including taking medications, scheduling appointments, handling medical bills, managing symptoms, monitoring health status and arranging help/transportation.

Outcome measures

Measure	Study Cohort n=60 Participants Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Time Spent on Cancer-related Care Tasks at Home	196 minutes per week Interval 116.0 to 321.0

PRIMARY outcome

Timeframe: 28 days

Summary of mobile app smartphone collected data from daily trips and surveys about time spent at home on cancer-related care tasks over 28 days, including out-of-home healthcare encounters, travel time, and at-home tasks including taking medications, scheduling appointments, handling medical bills, managing symptoms, monitoring health status and arranging help/transportation.

Outcome measures

Measure	Study Cohort n=60 Participants Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Time Spent on All Cancer-related Care Tasks (Out-of-home and at Home)	404 minutes per week Interval 265.0 to 599.0

PRIMARY outcome

Timeframe: 28 days

Summary of mobile app smartphone collected from daily-recorded trips away from home, collected over 28 days, focusing on those denoted as being related to cancer care (e.g. clinic visit, treatment, lab, pharmacy, imaging).

Outcome measures

Measure	Study Cohort n=60 Participants Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Out-of-home Cancer-related Healthcare Encounters	4.9 episodes per month Standard Deviation 3.1

Adverse Events

Study Cohort

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Rachel Vogel

University of Minnesota, Masonic Cancer Center

Phone: 612-624-6928

Email: isak0023@umn.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place